Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03662126
Title KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Acronym BOREAS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kartos Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | ROU | POL | LTU | ITA | ISR | HUN | HRV | GRC | GBR | FRA | ESP | DEU | CZE | CAN | BRA | BGR | AUS | ARG


No variant requirements are available.